{"id":"W4402103595","doi":"10.1016/j.jaad.2024.07.426","title":"54025 A Maximum-Use Trial of Ruxolitinib Cream in Children ≥2 to <12 Years Old with Atopic Dermatitis (AD): Patient-Reported Outcomes (PROs) at Week 8","year":2024,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Transgenic Plants and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Innovaderm (Canada)","funders":"","keywords":"Medicine; Atopic dermatitis; Ruxolitinib; Dermatology; Pediatrics; Internal medicine; Myelofibrosis","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006090283,0.0005861947,0.001347874,0.0001592569,0.0002393222,0.0005551068,0.0004162242,0.0008239402,0.005850227],"category_scores_gemma":[0.0005937245,0.0002271133,0.001308796,0.0001504755,0.0002636829,0.0005572275,0.0002324624,0.001779193,0.0008681208],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003950608,"about_ca_system_score_gemma":0.0002817038,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008297659,"about_ca_topic_score_gemma":0.002459468,"domain_scores_codex":[0.9997874,0.00007287041,0.00001246269,0.00004251499,0.00002212217,0.00006259635],"domain_scores_gemma":[0.9997438,0.00006419213,0.00005998476,0.00001334557,0.00001745864,0.0001013716],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7892994,0.01254913,0.01322256,0.001836248,0.003287834,0.0003761468,0.000152163,0.001262521,0.01134292,0.0004000994,0.008427225,0.1578437],"study_design_scores_gemma":[0.6035555,0.288177,0.09146892,0.000586235,0.002669453,0.0007129497,0.0001938803,0.001734663,0.0026602,0.0004090414,0.007756167,0.00007602802],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9856873,0.007917239,0.000199735,0.000442926,0.0002115939,0.000415629,0.001045004,0.00007114577,0.004009489],"genre_scores_gemma":[0.9935905,0.001774462,0.0003082701,0.0005227105,0.0001073988,0.0003979804,0.0009829126,0.000007716713,0.002308001],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005850227,"threshold_uncertainty_score":0.01957095,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01078352826150884,"score_gpt":0.2676892817890777,"score_spread":0.2569057535275689,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}